These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10727877)

  • 1. In vitro inhibition properties of a new group of thiobenzanilides in relation to yeasts.
    Matysiak J; Niewiadomy A; Macik-Niewiadomy G
    Eur J Pharm Sci; 2000 Apr; 10(2):119-23. PubMed ID: 10727877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of fungistatic activity of 2, 4-dihydroxythiobenzanilideson the structure and lipophilic nature of the compounds.
    Matysiak J; Niewiadomy A; Macik-Niewiadomy G; Kornillowicz T
    Eur J Med Chem; 2000 Apr; 35(4):393-404. PubMed ID: 10858600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-heterocyclic derivatives of 2,4-dihydroxybenzcarbothioamide as antimycotic agents.
    Matysiak J; Krajewska-Kułak E; Karczewski J; Niewiadomy A
    J Agric Food Chem; 2001 Nov; 49(11):5251-7. PubMed ID: 11714312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of 2,4-dihydroxythiobenzanilides against various moulds.
    Niewiadomy A; Matysiak J; Macik-Niewiadomy G
    Eur J Pharm Sci; 2001 Jun; 13(3):243-8. PubMed ID: 11384846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test.
    Nenoff P; Oswald U; Haustein UF
    Mycoses; 1999; 42(11-12):629-39. PubMed ID: 10680439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antimycotic activity of N-azolyl-2,4-dihydroxythiobenzamides.
    Matysiak J; Niewiadomy A
    Bioorg Med Chem; 2003 May; 11(10):2285-91. PubMed ID: 12713839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of clinical isolates of yeasts to anti-fungal agents.
    Hussain Qadri SM; Flournoy DJ; Qadri SG; Ramirez EG
    Mycopathologia; 1986 Sep; 95(3):183-7. PubMed ID: 3773980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal effect of Hevea brasiliensis latex with various fungi. Its synergistic action with amphotericin B against Candida albicans.
    Giordani R; Regli P; Buc J
    Mycoses; 2002 Dec; 45(11-12):476-81. PubMed ID: 12472724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on antifungal and antimycobacterial agents. Synthesis and activity of 4-alkylthiopyridine-2-carbothioamides.
    Klimesová V; Svoboda M; Waisser K; Machácek M; Buchta V; Odlerová Z
    Arch Pharm (Weinheim); 1996 Oct; 329(10):438-42. PubMed ID: 8933745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Characterization and Antifungal Evaluation of Novel Thiochromanone Derivatives Containing Indole Skeleton.
    Han XY; Zhong YF; Li SB; Liang GC; Zhou G; Wang XK; Chen BH; Song YL
    Chem Pharm Bull (Tokyo); 2016 Sep; 64(9):1411-6. PubMed ID: 27373770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro pharmacological study of fluconazole. Evaluation of an antifungal assay].
    Duval F; Lavarde V
    Pathol Biol (Paris); 1993 May; 41(5):469-73. PubMed ID: 8414680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Etest for direct antifungal susceptibility testing of yeasts in positive blood cultures.
    Chang HC; Chang JJ; Chan SH; Huang AH; Wu TL; Lin MC; Chang TC
    J Clin Microbiol; 2001 Apr; 39(4):1328-33. PubMed ID: 11283051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal effects of hydrolysable tannins and related compounds on dermatophytes, mould fungi and yeasts.
    Latté KP; Kolodziej H
    Z Naturforsch C J Biosci; 2000; 55(5-6):467-72. PubMed ID: 10928561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
    Fromtling RA; Yu HP; Shadomy S
    Mycopathologia; 1984 Apr; 86(1):45-50. PubMed ID: 6330557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process analysis of variables for standardization of antifungal susceptibility testing of nonfermentative yeasts.
    Zaragoza O; Mesa-Arango AC; Gómez-López A; Bernal-Martínez L; Rodríguez-Tudela JL; Cuenca-Estrella M
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1563-70. PubMed ID: 21245438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flucytosine primary resistance in Candida species and Cryptococcus neoformans.
    Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Rodríguez-Tudela JL
    Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):276-9. PubMed ID: 11399020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal and antibiofilm activities of halogenated quinoline analogues against Candida albicans and Cryptococcus neoformans.
    Zuo R; Garrison AT; Basak A; Zhang P; Huigens RW; Ding Y
    Int J Antimicrob Agents; 2016 Aug; 48(2):208-11. PubMed ID: 27256584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of artemisinin derivatives.
    Galal AM; Ross SA; Jacob M; ElSohly MA
    J Nat Prod; 2005 Aug; 68(8):1274-6. PubMed ID: 16124777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungicide activity of 5-(4-chlorobenzylidene)-(Z)-2-dimethylamino-1,3-thiazol-4-one against Cryptococcus neoformans.
    Insuasty B; Gutiérrez A; Quiroga J; Abonia R; Nogueras M; Cobo J; Svetaz L; Raimondi M; Zacchino S
    Arch Pharm (Weinheim); 2010 Jan; 343(1):48-53. PubMed ID: 19927310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.